2.1
|
Patent applications and granted patents in Bangladesh (1995–2012)
|
42
|
2.2
|
Mailbox applications (pharmaceutical and agrochemical products)
|
43
|
2.3
|
The DGDA controls the quality of medicines produced in Bangladesh
|
48
|
2.4
|
Changes required for TRIPS-compliant pharmaceutical regulation in Bangladesh
|
58
|
2.5
|
Allopathic pharmaceutical companies in Bangladesh
|
61
|
2.6
|
The top 10 pharmaceutical companies in Bangladesh (2014)
|
62
|
2.7
|
Multinational pharmaceutical companies operating in Bangladesh
|
63
|
2.8
|
Pharmaceutical exports from Bangladesh (1975–2006)
|
65
|
2.9
|
Survey results regarding whether Bangladesh has the capacity to produce new medicines
|
71
|
2.10
|
Survey results on whether TRIPS has influenced the rise in pharmaceutical prices
|
75
|
2.11
|
Top 10 drugs in terms of sales in Bangladesh
|
76
|
2.12
|
Changes in retail price of 10 important drugs
|
77
|
2.13
|
Causes of death in Bangladesh
|
78
|
2.14
|
Diseases prevalent in Bangladesh
|
79
|
3.1
|
Policy options used by Brazil, India and South Africa
|
144
|